Microbiota associated with type 2 diabetes and its related complications

Food Science and Human Wellness

Volumn 2, Issue 3-4, 2013, Pages 167-172

  Zhang, Yong ^a   Zhang, Heping ^a  

^a INNER MONGOLIA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Microbiota; T2DM complications; Type 2 diabetes

Indexed keywords

EID: 85069002032     PISSN: None     EISSN: 22134530     Source Type: Journal    
DOI: 10.1016/j.fshw.2013.09.002     Document Type: Review

References (81)

1. Gareau, M.G., Sherman, P.M., Walker, W.A., Probiotics and the gut microbiota in intestinal health and disease. Nature Reviews Gastroenterology & Hepatology 7:9 (2010), 503–514.
2. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:7122 (2006), 1027–1031.
3. Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology 9:5 (2009), 313–323.
4. McArdle, M.A., Finucane, O.M., Connaughton, R.M., McMorrow, A.M., Roche, H.M., Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Frontiers in Endocrinology, 4, 2013, 52.
5. Lee, J., Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 Diabetes. Archives of Pharmacal Research 36:2 (2013), 208–222.
6. Tilg, H., Kaser, A., Gut microbiome, obesity, and metabolic dysfunction. Journal of Clinical Investigation 121:6 (2011), 2126–2132.
7. Tremaroli, V., Bäckhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489:7415 (2012), 242–249.
8. Diamant, M., Blaak, E.E., Vos de, W.M., Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?. Obesity Reviews 12:4 (2011), 272–281.
9. Everard, A., Cani, P.D., Diabetes, obesity and gut microbiota. Best Practice & Research Clinical Gastroenterology 27:1 (2013), 73–83.
10. Devaraj, S., Hemarajata, P., Versalovic, J., The human gut microbiome and body metabolism: implications for obesity and diabetes. Clinical Chemistry 59:April (4)(2013), 617–628.
11. Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C., Li, L., Zhou, A., Wang, J., Moore, J.E., Millar, B.C., Xu, J., Molecular characterisation of the faecal microbiota in patients with type II diabetes. Current Microbiology 61:1 (2010), 69–78.
12. Larsen, N., Vogensen, F.K., van den Berg, F.W., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., Al-Soud, W.A., Sørensen, S.J., Hansen, L.H., Jakobsen, M., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 5, 2010, e9085.
13. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., Peng, Y., Zhang, D., Jie, Z., Wu, W., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:7418 (2012), 55–60.
14. Romano-Keeler, J., Weitkamp, J.H., Moore, D.J., Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetes. Current Opinion in Endocrinology, Diabetes and Obesity 19:2 (2012), 73–80.
15. Kootte, R.S., Vrieze, A., Holleman, F., Dallinga-Thie, G.M., Zoetendal, E.G., de Vos, W.M., Groen, A.K., Hoekstra, J.B., Stroes, E.S., Nieuwdorp, M., The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 14:2 (2012), 112–120.
16. Delzenne, N.M., Cani, P.D., Gut microbiota and the pathogenesis of insulin resistance. Current Diabetes Reports 11:3 (2011), 154–159.
17. Liou, A.P., Paziuk, M., Luevano, J.M., Machineni, S., Turnbaugh, P.J., Kaplan, L.M., Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Science Translational Medicine, 5(178), 2013, 178ra41.
18. Panwar, H., Rashmi, H.M., Batish, V.K., Grover, S., Probiotics as potential biotherapeutics in the management of type 2 diabetes – prospects and perspectives. Diabetes/Metabolism Research and Reviews 29:2 (2013), 103–112.
19. Lumeng, C.N., Saltiel, A.R., Inflammatory links between obesity and metabolic disease. Journal of Clinical Investigation 121:6 (2011), 2111–2117.
20. Donath, M.Y., Inflammation as a sensor of metabolic stress in obesity and type 2 diabetes. Endocrinology 152:11 (2011), 4005–4006.
21. Ouchi, N., Parker, J.L., Lugus, J.J., Walsh, K., Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 11:2 (2011), 85–97.
22. Matsuzaki, T., Yamazaki, R., Hashimoto, S., Yokokura, T., Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM)model using KK-Ay mice. Endocrine Journal 44 (1997), 357–365.
23. Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato, V., Marzotti, S., Corneli, R.B., Ferretti, E., Gulino, A., Grasso, F., De Simone, C., Di Mario, U., Falorni, A., Boirivant, M., Dotta, F., Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48 (2005), 1565–1575.
24. Chen, J.J., Wang, R., Li, X., Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Experimental Biology and Medicine 236 (2011), 823–831.
25. Hsieh, F.C., Lee, C.L., Chai, C.Y., Chen, W.T., Lu, Y.C., Wu, C.S., Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutrition & Metabolism, 10(1), 2013, 35.
26. Asemi, Z., Samimi, M., Tabassi, Z., Naghibi Rad, M., Rahimi Foroushani, A., Khorammian, H., Esmaillzadeh, A., Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial. European Journal of Clinical Nutrition 67:1 (2013), 71–74.
27. Asemi, Z., Jazayeri, S., Najafi, M., Samimi, M., Mofid, V., Shidfar, F., Foroushani, A.R., Shahaboddin, M.E., Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial. Pakistan Journal of Biological Sciences 14:8 (2011), 476–482.
28. Ejtahed, H.S., Mohtadi-Nia, J., Homayouni-Rad, A., Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 28:5 (2012), 539–543.
29. Asemi, Z., Jazayeri, S., Najafi, M., Samimi, M., Mofid, V., Shidfar, F., Shakeri, H., Esmaillzadeh, A., Effect of daily consumption of probiotic yogurt on oxidative stress in pregnant women: a randomized controlled clinical trial. Annals of Nutrition and Metabolism 60:1 (2012), 62–68.
30. Ooi, L.G., Liong, M.T., Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. International Journal of Molecular Sciences 11 (2010), 2499–2522.
31. Naito, E., Yoshida, Y., Makino, K., Kounoshi, Y., Kunihiro, S., Takahashi, R., Matsuzaki, T., Miyazaki, K., Ishikawa, F., Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. Journal of Applied Microbiology 110 (2011), 650–657.
32. Amar, J., Chabo, C., Waget, A., Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Molecular Medicine 3:9 (2011), 559–572.
33. Zhang, Y., Wang, L., Zhang, J., Li, Y., He, Q., Li, H., Guo, X., Guo, J., Zhang, H., Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. European Journal of Nutrition, 2013 (in press).
34. Fong, D.S., Aiello, L., Gardner, T.W., Retinopathy in diabetes. Diabetes Care 27:January (Suppl. 1)(2004), 84–87.
35. Martins, E.N., Alvarenga, L.S., Höfling-Lima, A.L., Freitas, D., Zorat-Yu, M.C., Farah, M.E., Mannis, M.J., Aerobic bacterial conjunctival flora in diabetic patients. Cornea 23:2 (2004), 136–142.
36. Karimsab, D., Razak, S.K., Study of aerobic bacterial conjunctival flora in patients with diabetes mellitus. Nepalese Journal of Ophthalmology 5:January (9)(2012), 28–32.
37. Bilen, H., Ates, O., Astam, N., Uslu, H., Akcay, G., Baykal, O., Conjunctival flora in patients with type 1 or type 2 diabetes mellitus. Advances in Therapy 24:5 (2007), 1028–1035.
38. Cereda, E., Barichella, M., Pedrolli, C., Klersy, C., Cassani, E., Caccialanza, R., Pezzoli, G., Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care 34:12 (2011), 2614–2623.
39. Kusbeci, T., Kusbeci, O.Y., Aktepe, O.C., Yavas, G., Ermis, S.S., Conjunctival flora in patients with Parkinson's disease. Current Eye Research 34:4 (2009), 251–256.
40. Vaziri, N.D., Wong, J., Pahl, M., Piceno, Y.M., Yuan, J., DeSantis, T.Z., Ni, Z., Nguyen, T.H., Andersen, G.L., Chronic kidney disease alters intestinal microbial flora. Kidney International 83:2 (2013), 308–315.
41. Zheng, X., Zhao, A., Xie, G., Chi, Y., Zhao, L., Li, H., Wang, C., Bao, Y., Jia, W., Luther, M., Su, M., Nicholson, J.K., Jia, W., Melamine-induced renal toxicity is mediated by the gut microbiota. Science Translational Medicine, 5(172), 2013, 172ra22.
42. Duncan, S.H., Richardson, A.J., Kaul, P., Holmes, R.P., Allison, M.J., Stewart, C.S., Oxalobacter formigenes and its potential role in human health. Applied and Environmental Microbiology 68 (2002), 3841–3847.
43. Turroni, S., Vitali, B., Bendazzoli, C., Candela, M., Gotti, R., Federici, F., Pirovano, F., Brigidi, F., Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. Journal of Applied Microbiology 103:5 (2007), 1600–1609.
44. Borghi, L., Nouvenne, A., Meschi, T., Probiotics and dietary manipulations in calcium oxalate nephrolithiasis: two sides of the same coin?. Kidney International 78:11 (2010), 1063–1065.
45. Stafford, D.W., The vitamin K cycle. Journal of Thrombosis and Haemostasis 3:8 (2005), 1873–1878.
46. Hu, B., Wang, T., Liu, Z., Guo, X., Yang, J., Liu, J., Wang, S., Ye, Z., Decreased expression of vitamin K epoxide reductase complex subunit 1 in kidney of patients with calcium oxalate urolithiasis. Journal of Huazhong University of Science and Technology 31:6 (2011), 807–814.
47. Pluznick, J.L., Protzko, R.J., Gevorgyan, H., Peterlin, Z., Sipos, A., Han, J., Brunet, I., Wan, L.X., Rey, F., Wang, T., Firestein, S.J., Yanagisawa, M., Gordon, J.I., Eichmann, A., Peti-Peterdi, J., Caplan, M.J., Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proceedings of the National Academy of Sciences of the United States of America 110:11 (2013), 4410–4415.
48. Tanida, M., Yamano, T., Maeda, K., Okumura, N., Fukushima, Y., Nagai, K., Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats. Neuroscience Letters 389:2 (2005), 109–114.
49. Yamano, T., Tanida, M., Niijima, A., Maeda, K., Okumura, N., Fukushima, Y., Nagai, K., Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats. Life Sciences 79:20 (2006), 1963–1967.
50. Koren, O., Spor, A., Felin, J., Fåk, F., Stombaugh, J., Tremaroli, V., Behre, C.J., Knight, R., Fagerberg, B., Ley, R.E., Bäckhed, F., Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 108:Suppl. 1 (2011), 4592–4598.
51. Moroti, C., Souza Magri, L.F., de Rezende Costa, M., Cavallini, D.C., Sivieri, K., Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids in Health and Disease, 11, 2012, 29.
52. Milla, C.E., Billings, J., Moran, A., Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 28:9 (2005), 2141–2144.
53. Harrison, F., Microbial ecology of the cystic fibrosis lung. Microbiology 153:4 (2007), 917–923.
54. Goddard, A.F., Staudinger, B.J., Dowd, S.E., Joshi-Datar, A., Wolcott, R.D., Aitken, M.L., Fligner, C.L., Singh, P.K., Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proceedings of the National Academy of Sciences of the United States of America 109:34 (2012), 13769–13774.
55. Madan, J.C., Koestler, D.C., Stanton, B.A., Davidson, L., Moulton, L.A., Housman, M.L., Moore, J.H., Guill, M.F., Morrison, H.G., Sogin, M.L., Hampton, T.H., Karagas, M.R., Palumbo, P.E., Foster, J.A., Hibberd, P.L., O'Toole, G.A., Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. mBio, 3(4), 2012, e00251.
56. Bruzzese, E., Raia, V., Gaudiello, G., Polito, G., Buccigrossi, V., Formicola, V., Guarino, A., Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Alimentary Pharmacology & Therapeutics 20:7 (2004), 813–819.
57. Weiss, B., Bujanover, Y., Yahav, Y., Vilozni, D., Fireman, E., Efrati, O., Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatric Pulmonology 45:6 (2010), 536–540.
58. Roy, C.C., Delage, G., Fontaine, A., Robitaille, L., Chartrand, L., Weber, A., Morin, C.L., The fecal microflora and bile acids in children with cystic fibrosis. American Journal of Clinical Nutrition 32:12 (1979), 2404–2409.
59. Grice, E.A., Segre, J.A., The skin microbiome. Nature Reviews Microbiology 9:4 (2011), 244–253.
60. Redel, H., Gao, Z., Li, H., Alekseyenko, A.V., Zhou, Y., Perez-Perez, G.I., Weinstock, G., Sodergren, E., Blaser, M.J., Quantitation and composition of cutaneous microbiota in diabetic and nondiabetic men. Journal of Infectious Diseases 207:7 (2013), 1105–1114.
61. Gardner, S.E., Hillis, S.L., Heilmann, K., Segre, J.A., Grice, E.A., The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 62:3 (2013), 923–930.
62. Akter, K., Lanza, E.A., Martin, S.A., Myronyuk, N., Rua, M., Raffa, R.B., Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?. British Journal of Clinical Pharmacology 71:3 (2011), 365–376.
63. Vagelatos, N.T., Eslick, G.D., Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiologic Reviews, 2013 (in press).
64. Vignini, A., Giulietti, A., Nanetti, L., Raffaelli, F., Giusti, L., Mazzanti, L., Provinciali, L., Alzheimer's disease and diabetes: new insights and unifying therapies. Current Diabetes Reviews 9:3 (2013), 218–227.
65. de la Monte, S.M., Wands, J.R., Alzheimer's disease is type 3 diabetes-evidence reviewed. Journal of Diabetes Science and Technology 2:6 (2008), 1101–1113.
66. Karri, S., Acosta-Martinez, V., Coimbatore, G., Effect of dihydrotestosterone on gastrointestinal tract of male Alzheimer's disease transgenic mice. Indian Journal of Experimental Biology 48:5 (2010), 453–465.
67. Bendheim, P.E., Poeggeler, B., Neria, E., Ziv, V., Pappolla, M.A., Chain, D.G., Development of indole-3-propionic acid (OXIGON)for Alzheimer's disease. Journal of Molecular Neuroscience 19:1–2 (2002), 213–217.
68. Kuhn, B., Hilpert, H., Benz, J., Binggeli, A., Grether, U., Humm, R., Märki, H.P., Meyer, M., Mohr, P., Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists. Bioorganic & Medicinal Chemistry Letters 16:15 (2006), 4016–4020.
69. Wikoff, W.R., Anfora, A.T., Liu, J., Schultz, P.G., Lesley, S.A., Peters, E.C., Siuzdak, G., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences of the United States of America 106:10 (2009), 3698–3703.
70. Limon, A., Reyes-Ruiz, J.M., Miledi, R., Loss of functional GABA(A)receptors in the Alzheimer diseased brain. Proceedings of the National Academy of Sciences of the United States of America 109:25 (2012), 10071–10076.
71. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Bienenstock, J., Cryan, J.F., Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve[J]. Proceedings of the National Academy of Sciences of the United States of America 108:38 (2011), 16050–16055.
72. Nowlin, S.Y., Hammer, M.J., D'Eramo Melkus, G., Diet, inflammation, and glycemic control in type 2 diabetes: an integrative review of the literature. Journal of Nutrition and Metabolism, 2012, 2012, 542698.
73. Fowler, M.J., Diabetes treatment. Part 2: Oral agents for glycemic management. Clinical Diabetes 25:4 (2007), 131–134.
74. Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., Li, X., Ning, G., Zhao, L., Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One, 7(8), 2012, e42529.
75. Wang, H.Y., Qi, L.W., Wang, C.Z., Li, P., Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosides. American Journal of Chinese Medicine 39:6 (2011), 1103–1115.
76. Bischoff, H., Pharmacology of alpha-glucosidase inhibition. European Journal of Clinical Investigation 24:Suppl. 3 (1994), 3–10.
77. Crozier, A., Jaganath, I.B., Clifford, M.N., Dietary phenolics: chemistry, bio-availability and effects on health. Natural Product Reports 26:8 (2009), 1001–1043.
78. Bisbal, C., Lambert, K., Avignon, A., Antioxidants and glucose metabolism disorders. Current Opinion in Clinical Nutrition & Metabolic Care 13:4 (2010), 439–446.
79. Hanhineva, K., Törrönen, R., Bondia-Pons, I., Pekkinen, J., Kolehmainen, M., Mykkänen, H., Poutanen, K., Impact of dietary polyphenols on carbohydrate metabolism. International Journal of Molecular Sciences 11:4 (2010), 1365–1402.
80. Queipo-Ortuño, M.I., Boto-Ordóñez, M., Murri, M., Gomez-Zumaquero, J.M., Clemente-Postigo, M., Estruch, R., Cardona Diaz, F., Andrés-Lacueva, C., Tinahones, F.J., Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. American Journal of Clinical Nutrition 95:6 (2012), 1323–1334.
81. Calani, L., Dall'Asta, M., Derlindati, E., Scazzina, F., Bruni, R., Rio Del, D., Colonic metabolism of polyphenols from coffee, green tea, and hazelnut skins. Journal of Clinical Gastroenterology 46:Suppl. (2012), 95–99.